BR9407971A - Produto pseudodipeptideo processo químico e enzimático de preparaçao do mesmo aplicaçao do produto e medicamento resultante da aplicaçao - Google Patents

Produto pseudodipeptideo processo químico e enzimático de preparaçao do mesmo aplicaçao do produto e medicamento resultante da aplicaçao

Info

Publication number
BR9407971A
BR9407971A BR9407971A BR9407971A BR9407971A BR 9407971 A BR9407971 A BR 9407971A BR 9407971 A BR9407971 A BR 9407971A BR 9407971 A BR9407971 A BR 9407971A BR 9407971 A BR9407971 A BR 9407971A
Authority
BR
Brazil
Prior art keywords
product
application
preparation
pseudodipeptide
enzymatic process
Prior art date
Application number
BR9407971A
Other languages
English (en)
Inventor
Marc Babizhayev
Original Assignee
Exsymbol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exsymbol filed Critical Exsymbol
Publication of BR9407971A publication Critical patent/BR9407971A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
BR9407971A 1993-11-05 1994-11-03 Produto pseudodipeptideo processo químico e enzimático de preparaçao do mesmo aplicaçao do produto e medicamento resultante da aplicaçao BR9407971A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9313480A FR2711990B1 (fr) 1993-11-05 1993-11-05 Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires.
PCT/FR1994/001272 WO1995012581A1 (fr) 1993-11-05 1994-11-03 Produit pseudodipeptide possedant un groupement imidazole et applications

Publications (1)

Publication Number Publication Date
BR9407971A true BR9407971A (pt) 1996-12-03

Family

ID=9452766

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9407971A BR9407971A (pt) 1993-11-05 1994-11-03 Produto pseudodipeptideo processo químico e enzimático de preparaçao do mesmo aplicaçao do produto e medicamento resultante da aplicaçao

Country Status (17)

Country Link
US (1) US6046340A (pt)
EP (1) EP0726895B1 (pt)
JP (1) JP3503899B2 (pt)
KR (1) KR100363812B1 (pt)
CN (1) CN1056608C (pt)
BR (1) BR9407971A (pt)
CA (1) CA2174526C (pt)
CZ (1) CZ292108B6 (pt)
DE (1) DE69425153T2 (pt)
ES (1) ES2149951T3 (pt)
FR (1) FR2711990B1 (pt)
GR (1) GR3034543T3 (pt)
HU (1) HU222566B1 (pt)
PT (1) PT726895E (pt)
RU (1) RU2159775C2 (pt)
UA (1) UA56123C2 (pt)
WO (1) WO1995012581A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786326A (en) * 1995-02-03 1998-07-28 Horwitz; Lawrence D. Method for the treatment of atherosclerosis and vascular injury by prevention of vascular smooth muscle cell proliferation
CA2222099A1 (en) * 1995-05-30 1996-12-05 Gliatech, Inc. 1h-4(5)-substituted imidazole derivatives
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
RU2141968C1 (ru) * 1997-07-04 1999-11-27 Небольсин Владимир Евгеньевич Способ получения гамма-l-глутамилгистамина, применение гамма-l-глутамилгистамина, фармацевтическая композиция
FR2769838B1 (fr) * 1997-10-16 2000-04-07 Roc Sa Utilisation de derives d'azole pour la preparation d'une composition dermatologique ou cosmetologique
FR2778562B1 (fr) * 1998-05-14 2000-08-04 Sephra Composition pharmaceutique, hygienique et/ou cosmetique contenant de l'eau de mer et de l'arginine
PT1037627E (pt) * 1998-07-14 2001-11-30 Alcon Lab Inc Utilizacao do acido 11-(3-dimetilaminopropilideno)-6,11-dihidrodibenz¬b,e|oxepin-2-acetico e seus sais derivados farmaceuticamente aceitaveis para a producao de um medicamento para o tratamento de doencas inflamatorias oftalmicas nao-alergicas e para a prebencao da neovascularizacao ocular
US6417397B1 (en) * 1999-10-04 2002-07-09 The Regents Of The University Of California, San Diego N-substituted alkylamino acids for use as amino-protecting groups
US6552010B1 (en) * 1999-11-12 2003-04-22 Genelabs Technologies, Inc. Treatment of SLE with dehydroepiandrosterone
EP1125925A1 (en) * 2000-02-15 2001-08-22 Applied Research Systems ARS Holding N.V. Amine derivatives for the treatment of apoptosis
JP3920641B2 (ja) * 2000-04-14 2007-05-30 ナイアダイン コーポレーション タンパク質−後期糖化反応生成物（タンパク質−ａｇｅ）形成の調節因子を同定する方法
WO2002069985A2 (en) * 2001-03-05 2002-09-12 Forinnova As Immune response potentiation
MC200060A1 (fr) 2002-10-04 2003-05-28 M Exsymol Sa Produit de couplage entre la tryptamine et un alpha-aminoacide son procédé de préparation et son application dans le domaine de la neuro-cosmétique
EP1661565B1 (en) * 2003-08-05 2007-10-24 Centro de Histoterapia Placentaria Composition comprising l-proline for the treatment of vitiligo
US8668703B2 (en) * 2006-12-01 2014-03-11 Wake Forest University Health Sciences Medical devices incorporating collagen inhibitors
FR2992644B1 (fr) * 2012-07-02 2015-07-03 Exsymol Sa Famille de composes arylethylamides polyamines, et leurs applications cosmetiques ou dermocosmetiques
MC200154A1 (fr) * 2012-07-02 2013-01-23 Exsymol Sa Famille de composés aryléthylamides polyaminés, et leurs applications cosmétiques ou dermocosmétiques
KR102276326B1 (ko) 2013-03-13 2021-07-13 앙테이스 에스.아. 피부 회춘을 위한 펩타이드 및 이것을 사용하는 방법
WO2015114176A1 (es) * 2014-01-31 2015-08-06 Dermopartners, S.L. Producto cosmético con propiedades contra el envejecimiento de la piel
CN116249522A (zh) * 2020-07-20 2023-06-09 深圳迈瑞生物医疗电子股份有限公司 一种组合物的血小板解聚用途、解聚试剂及解聚方法
CN114989091B (zh) * 2022-06-14 2025-03-21 水羊化妆品制造有限公司 一种谷氨酰胺基乙基咪唑的制备方法
FR3151760A1 (fr) * 2023-08-01 2025-02-07 Exsymol Nouvelles utilisations de dérivés imidazolyls
CN117143022B (zh) * 2023-08-30 2024-07-26 上海克琴科技有限公司 一种谷氨酰胺基乙基咪唑的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2301532A (en) * 1938-08-18 1942-11-10 Parke Davis & Co Biological product and process of obtaining same
US2581814A (en) * 1947-10-04 1952-01-08 Ralph L Evans Preparation of glutamyl histidine
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4613676A (en) * 1983-11-23 1986-09-23 Ciba-Geigy Corporation Substituted 5-amino-4-hydroxyvaleryl derivatives
EP0144290A3 (de) * 1983-12-01 1987-05-27 Ciba-Geigy Ag Substituierte Aethylendiaminderivate
US4996221A (en) * 1987-01-13 1991-02-26 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives as immune modulators
IL92441A (en) * 1988-12-07 1993-05-13 Tanabe Seiyaku Co Imidazole containing peptides, their preparation and pharmaceutical compositions containing them
US4962120A (en) * 1989-03-22 1990-10-09 Sterling Drug Inc. 1H-imidazole-1-acetamides
DE69118784T2 (de) * 1990-08-17 1996-09-19 Japan Tobacco Inc Neue Peptidderivate und deren pharmazeutischer Gebrauch
FR2701948B1 (fr) * 1993-02-22 1996-07-26 Exsymol Sa Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires.

Also Published As

Publication number Publication date
EP0726895B1 (fr) 2000-07-05
DE69425153D1 (de) 2000-08-10
CZ292108B6 (cs) 2003-07-16
HU9600989D0 (en) 1996-06-28
PT726895E (pt) 2000-12-29
WO1995012581A1 (fr) 1995-05-11
HU222566B1 (hu) 2003-08-28
CZ115596A3 (en) 1996-12-11
US6046340A (en) 2000-04-04
GR3034543T3 (en) 2001-01-31
ES2149951T3 (es) 2000-11-16
RU2159775C2 (ru) 2000-11-27
JPH09504540A (ja) 1997-05-06
UA56123C2 (uk) 2003-05-15
EP0726895A1 (fr) 1996-08-21
CN1056608C (zh) 2000-09-20
KR100363812B1 (ko) 2003-02-11
CA2174526A1 (fr) 1995-05-11
CN1136808A (zh) 1996-11-27
FR2711990B1 (fr) 1995-12-08
JP3503899B2 (ja) 2004-03-08
HUT74387A (en) 1996-12-30
DE69425153T2 (de) 2001-03-15
FR2711990A1 (fr) 1995-05-12
KR960705785A (ko) 1996-11-08
CA2174526C (fr) 2009-08-18

Similar Documents

Publication Publication Date Title
BR9408148A (pt) Processo para tratamento de arritmia composto e formulação farmacêutica
BR9406126A (pt) Produto pseudo-dipeptícico,processo químico e enzimático de preparação do mesmo aplicação do produto e medicamento
FI980561L (fi) Pneumokokkaalliset geenit, niiden osat, ilmentämistuotteet niistä ja sellaisten geenien, osien ja tuotteiden käytöt
BR9404114A (pt) Composição farmacêutica e seu processo de preparação
DE69429493D1 (de) Verbinder und dessen Herstellungsverfahren
DE69624248D1 (de) Verbesserter tft, dessen herstellungsverfahren und den tft enthaltende matrixanzeigen
BR9611198A (pt) Composto processo de preparação do mesmo e composição farmacêutica
BR9407869A (pt) Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose
NO932662L (no) Fremgangsmåte for fremstilling av kitin og kitosan av biomedisinsk kvalitet
AU7368494A (en) Treatment of tachyarrhythmias of supraventricular origin
AU6023596A (en) Process and product for the treatment of arthritis
IT1249208B (it) Processo per la preparazione di 1,3-diossolani alogenati e nuovi prodotti ottenuti
BR9609602A (pt) Composição cosmética anidra utilização da composição e processo de tratamento cosmético
ITRM940135A0 (it) Procedimento a bagno singolo e composizione per il trattamento di prodotti tessili.
BR9607413A (pt) Processo para produçao de pentafluoretano e tetrafluorcloroetano
BR9600254A (pt) Composto processo para a sua preparação seus usos método para o tratamento de arritmias e medicamento contendo o mesmo
NO955258D0 (no) Medisinsk anvendelse av enzymer
DE69419639D1 (de) Verfahren zur Herstellung von Fructose-2,6-diphosphat und Reinigungsverfahren hierfür
PT719499E (pt) Processo de tratamento anti-germinativo de tuberculos ou bolbos
ITRM930502A0 (it) Procedimento per la produzione di r amminocarnitina e s amminocarnitina.
EP0817817A4 (en) NEW MOLECULES OPPOSING ICE FORMATION AND THEIR APPLICATIONS
BR9610851A (pt) Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto
ITMI931828A0 (it) Processo per la preparazione di pentafluoroetano
BR9600371A (pt) Processo de tratamento de madeira e produto de madeira
IT8920816A0 (it) Processo di desolforazione anaerobica di petroli e prodotti petroliferi.

Legal Events

Date Code Title Description
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: C07D 233/64 (2006.01), A61K 8/64 (2006.0